Dr Tom Ewen
Stuart Horswell
Dr Helen Bosomworth
Joe Lowenstein
Grant Richardson
et al. | Validation of epidermal AMBRA1 and loricrin (AMBLor) as a prognostic biomarker for nonulcerated American Joint Committee on Cancer stage I/II cutaneous melanoma | 2024 |
|
Dr Ioana Cosgarea
Dr Ashleigh McConnell
Dr Tom Ewen
Dr Diana Tang
Dr David Hill
et al. | Melanoma secretion of transforming growth factor-β2 leads to loss of epidermal AMBRA1 threatening epidermal integrity and facilitating tumour ulceration | 2022 |
|
Dr Robert Ellis
Dr Diana Tang
Dr Batoul Nasr
Alison Greenwood
Dr Ashleigh McConnell
et al. | Epidermal autophagy and beclin 1 regulator 1 and loricrin: a paradigm shift in the prognostication and stratification of the American Joint Committee on Cancer stage I melanomas | 2020 |
|
Christopher McKee
Dr David Hill
Dr Chris Redfern
Dr Jane Armstrong
Professor Penny Lovat
et al. | Oncogenic BRAF signalling increases Mcl-1 expression in cutaneous metastatic melanoma | 2013 |
|
